Area of research
Hematology · Cancer Research
Research interest
Research interests include Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Neutropenia and Cancer Infections.
Human plasma proteomic profile of clonal hematopoiesis
<i>JAK2</i>-mutant clonal hematopoiesis is associated with venous thromboembolism
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Clonal haematopoiesis and risk of chronic liver disease
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
Clonal Hematopoiesis in Young Women Treated for Breast Cancer
Association of Somatic <scp><i>TET2</i></scp> Mutations With Giant Cell Arteritis
Clonal Hematopoiesis and Venous Thromboembolism in the UK Biobank
Author Correction: Clonal haematopoiesis and risk of chronic liver disease
<i>STAG2</i> Somatic Mutations Are Associated with Specific Dysplastic Megakaryocytic and Myeloid Cell Features in Myelodysplastic Syndrome
<i>TET2</i>-mutant clonal hematopoiesis and risk of gout
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
Distinction of lymphoid and myeloid clonal hematopoiesis
Association of clonal hematopoiesis with chronic obstructive pulmonary disease
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
<i>Dnmt3a</i> -mutated clonal hematopoiesis promotes osteoporosis
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy
Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes